Experimental prostate cancer therapy delays disease in 'landmark' trial - CNN

[unable to retrieve full-text content]
  1. Experimental prostate cancer therapy delays disease in 'landmark' trial  CNN
  2. First prostate cancer therapy to target genes delays cancer progression  Medical Xpress
  3. Targeted therapy slows progression of advanced prostate cancer  EurekAlert
  4. Olaparib trial reveals 'first personalized treatment strategy for prostate cancer'  Healio
  5. Thousands of British men with advanced prostate cancer are set to get the first 'precision' drug  Daily Mail
  6. View full coverage on Google News


https://ift.tt/2oM1c0d

Comments

Popular posts from this blog

Q&A

Sentinel lymph node biopsy: What cancer patients should know

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...